Pharmaceuticals and Biotechnology Companies
In recent years, NERA has represented clients in over 50 antitrust and competition matters involving pharmaceutical and biotechnology companies, including investigations before US and EU regulatory authorities, cases involving reverse payments, civil lawsuits alleging anticompetitive behavior, and pre-merger economic analysis and consulting.
Antitrust and Competition
Intellectual Property
NERA’s intellectual property economists, survey experts, and social scientists have represented clients in more than 100 matters involving branded and generic pharmaceuticals, over-the-counter medications, and dietary supplements.
Product Liability and Mass Torts
NERA experts have analyzed personal injury and product liability issues since the early 2000s, assisting companies with projects related to product recalls, damages claims, insurance disputes, mergers and acquisitions, and consumer class actions.
Securities and Finance
NERA is widely recognized as a leading provider of economic and financial analysis in securities and finance matters. Our experts work with directors and offices, regulators, and other entities in
bet-the-company matters including mass torts, shareholder class actions, white collar criminal and regulatory enforcement actions, and commercial disputes.
Transfer Pricing
NERA’s global transfer pricing experts frequently represent pharmaceutical clients in matters before national and international tax authorities, serve as expert witnesses in litigation and arbitration, and provide guidance to regulatory bodies responsible for domestic and global tax policy.
Antitrust and Competition
Our experts combine institutional knowledge of the medical device market and a rigorous economic approach with a deep understanding of antitrust and competition law to assist clients in the medical device and technology industries.
Intellectual Property
NERA’s intellectual property economists work with clients in the medical device industry to determine damages in connection with infringement and breach-of-contract claims involving patents and trade secrets, address such issues as irreparable harm and the impact of alleged false or misleading advertising, and value intellectual property.
Product Liability and Mass Torts
NERA economists work with medical device companies on projects related to product recalls, damages claims, insurance disputes, mergers and acquisitions, and consumer class actions.
Securities and Finance
NERA’s securities and finance economists work with clients in the medical device and medical equipment industries to address allegations of product liability and securities fraud, assist in resolving commercial disputes, and manage financial, legal, and securities risks.
Transfer Pricing
Based in Europe and the US, NERA’s transfer pricing economists provide clients in the medical device and medical technology industries with expert analysis, valuation support, and advice on domestic and cross-border tax and valuation matters and serve as expert witnesses in tax litigation and arbitration matters.
Medical Device Manufacturers
Click to See Medical Device Manufacturers
Click to See Pharmaceuticals and Biotechnology Companies
Learn more about NERA’s wide-ranging support for
clients in the life sciences industry:
• Antitrust and Competition
• Intellectual Property
• Product Liability and Mass Torts
• Securities and Finance
• Transfer Pricing
• Antitrust and Competition
• Intellectual Property
• Product Liability and Mass Torts
• Securities and Finance
• Transfer Pricing
Learn more about NERA’s wide-ranging support for
clients in the life sciences industry:
